FDA 483 - Indoco Remedies Limited - July 26, 2024
An FDA inspection of Indoco Remedies Limited in Vasco Da Gama, Goa, India, revealed significant deficiencies in both sterile and non-sterile drug manufacturing. Key issues included inadequate complaint investigations, failures in aseptic process validation, and a lack of adherence to quality control unit responsibilities. The firm also exhibited poor facility maintenance, insufficient environmental monitoring, and deficiencies in in-process material testing, indicating a broad range of cGMP violations.
ID · 356b669e-1931-4335-90e7-4a58711730a8
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.